Also, increased C5a levels in urine have been identified as a valuable and accurate biomarker to stratify diabetic patients with DKD into rapid and slow progressors, implying that urine C5a levels are a reliable predictor of progression to end-stage kidney disease (ESKD). Here, C5AR1 is linked to diabetic kidney disease.